209 related articles for article (PubMed ID: 25399693)
1. Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles.
Koelsche C; Hovestadt V; Jones DT; Capper D; Sturm D; Sahm F; Schrimpf D; Adeberg S; Böhmer K; Hagenlocher C; Mechtersheimer G; Kohlhof P; Mühleisen H; Beschorner R; Hartmann C; Braczynski AK; Mittelbronn M; Buslei R; Becker A; Grote A; Urbach H; Staszewski O; Prinz M; Hewer E; Pfister SM; von Deimling A; Reuss DE
Brain Pathol; 2015 Mar; 25(2):202-8. PubMed ID: 25399693
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
[TBL] [Abstract][Full Text] [Related]
3. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
4. Papillary Tumor of the Pineal Region: A Distinct Molecular Entity.
Heim S; Sill M; Jones DT; Vasiljevic A; Jouvet A; Fèvre-Montange M; Wesseling P; Beschorner R; Mittelbronn M; Kohlhof P; Hovestadt V; Johann P; Kool M; Pajtler KW; Korshunov A; Ruland V; Sperveslage J; Thomas C; Witt H; von Deimling A; Paulus W; Pfister SM; Capper D; Hasselblatt M
Brain Pathol; 2016 Mar; 26(2):199-205. PubMed ID: 26113311
[TBL] [Abstract][Full Text] [Related]
5. Sporadic melanotic schwannoma with overlapping features of melanocytoma bearing a GNA11 mutation in an adolescent girl.
Tatsi C; Bacopoulou F; Lyssikatos C; Belyavskaya E; Faucz FR; Stratakis CA
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 28012237
[TBL] [Abstract][Full Text] [Related]
6. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
[TBL] [Abstract][Full Text] [Related]
7. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
8. Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis.
Küsters-Vandevelde HV; Kruse V; Van Maerken T; Boterberg T; Pfundt R; Creytens D; Van den Broecke C; Machielsen TC; Koelsche C; von Deimling A; Küsters B; Groenen PJ; Wesseling P; Blokx WA
Exp Mol Pathol; 2017 Feb; 102(1):25-31. PubMed ID: 27974237
[TBL] [Abstract][Full Text] [Related]
9. Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.
Küsters-Vandevelde HV; van Engen-van Grunsven IA; Küsters B; van Dijk MR; Groenen PJ; Wesseling P; Blokx WA
Acta Neuropathol; 2010 Dec; 120(6):755-64. PubMed ID: 20865267
[TBL] [Abstract][Full Text] [Related]
10. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
[TBL] [Abstract][Full Text] [Related]
11. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
[TBL] [Abstract][Full Text] [Related]
12. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.
Hölsken A; Sill M; Merkle J; Schweizer L; Buchfelder M; Flitsch J; Fahlbusch R; Metzler M; Kool M; Pfister SM; von Deimling A; Capper D; Jones DT; Buslei R
Acta Neuropathol Commun; 2016 Feb; 4():20. PubMed ID: 26927026
[TBL] [Abstract][Full Text] [Related]
13. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ
Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
15. Melanotic Schwannoma of the Vulva: A Case Report and Review of the Literature.
Cohen JN; Yeh I; LeBoit PE
Am J Dermatopathol; 2020 Jan; 42(1):46-51. PubMed ID: 31268928
[TBL] [Abstract][Full Text] [Related]
16. High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.
Díaz de Ståhl T; Hansson CM; de Bustos C; Mantripragada KK; Piotrowski A; Benetkiewicz M; Jarbo C; Wiklund L; Mathiesen T; Nyberg G; Collins VP; Evans DG; Ichimura K; Dumanski JP
Hum Genet; 2005 Oct; 118(1):35-44. PubMed ID: 16078050
[TBL] [Abstract][Full Text] [Related]
17. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
18. Trisomy 6p and ring chromosome 11 in a melanotic schwannoma suggest relation to malignant melanoma rather than conventional schwannoma.
Italiano A; Michalak S; Soulié P; Peyron AC; Pedeutour F
Acta Neuropathol; 2011 May; 121(5):669-70. PubMed ID: 21424748
[No Abstract] [Full Text] [Related]
19. Mutation analysis of metastatic melanomas in the central nervous system: results of a panel of 5 genes in 48 cases.
Gamsizkan M; Yilmaz I; Simsek HA; Onguru O; Griffin A; Tihan T
Clin Neuropathol; 2016; 35(4):178-85. PubMed ID: 27117140
[TBL] [Abstract][Full Text] [Related]
20. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O
Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
